GH Q3 2024 Earnings — Guardant Health, Inc. Revenue & Financial Results | Market Cap Arena

GHGuardant Health, Inc.

$12B

Q3 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$191M+33.9% YoY

Gross Profit

$117M61.1% margin

Operating Income

-$117M-61.3% margin

Net Income

-$108M-56.3% margin

EPS (Diluted)

$-0.88

QoQ Revenue Growth

+8.0%

Cash Flow

Operating Cash Flow

-$51M

Free Cash Flow

-$55M

Stock-Based Comp.

$50M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$1.6B

Stockholders' Equity

-$60M

Cash & Equivalents

$688M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$191M	$143M	+33.9%
Gross Profit	$117M	$85M	+37.0%
Operating Income	-$117M	-$114M	-3.3%
Net Income	-$108M	-$86M	-25.1%

Geographic Segments

UNITED STATES

$180M94%

Non-US

$11M6%